Shares of BMO Capital Markets (:) have been given a consensus rating of “N/A” by the zero analysts that are presently covering the firm, Marketbeat reports.
TRADEMARK VIOLATION WARNING: This report was first reported by Rincon Hill News and is owned by of Rincon Hill News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://rinconhillneighbors.org/2017/08/19/analysts-anticipate-fortress-biotech-inc-nasdaqfbio-will-post-quarterly-sales-of-45-83-million-updated-updated.html.
BMO Capital Markets Company Profile
BMO Capital Markets is the investment banking and capital markets arm of Bank of Montreal, aka BMO Financial Group. It serves corporate, institutional, and government clients in North America, providing equity and debt underwriting, corporate lending and project finance, M&A advisory, and equity and debt research.
Receive News & Ratings for BMO Capital Markets Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BMO Capital Markets and related companies with our FREE daily email newsletter.